Active Ingredient: ALCOHOL
Proprietary Name: ABLYSINOL
Dosage Form; Route of Administration: SOLUTION; INTRA-ARTERIAL
Strength: 99% (1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N207987
Product Number: 001
Approval Date: Jun 21, 2018
Applicant Holder Full Name: BPI LABS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information